These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35845273)

  • 1. A novel cause of
    Arthur JW; Pickett HA; Barbaro PM; Kilo T; Vasireddy RS; Beilharz TH; Powell DR; Hackett EL; Bennetts B; Curtin JA; Jones K; Christodoulou J; Reddel RR; Teo J; Bryan TM
    EJHaem; 2021 May; 2(2):157-166. PubMed ID: 35845273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Variant and a Missense Variant Identified in the
    Yuan C; Deng D; Yang J; Liu S; Qian Q; Chen M; Zhou S; Li Y; Li M
    Clin Cosmet Investig Dermatol; 2022; 15():1837-1845. PubMed ID: 36111181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired Telomere Maintenance and Decreased Canonical WNT Signaling but Normal Ribosome Biogenesis in Induced Pluripotent Stem Cells from X-Linked Dyskeratosis Congenita Patients.
    Gu BW; Apicella M; Mills J; Fan JM; Reeves DA; French D; Podsakoff GM; Bessler M; Mason PJ
    PLoS One; 2015; 10(5):e0127414. PubMed ID: 25992652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere dynamics and hematopoietic differentiation of human DKC1-mutant induced pluripotent stem cells.
    Donaires FS; Alves-Paiva RM; Gutierrez-Rodrigues F; da Silva FB; Tellechea MF; Moreira LF; Santana BA; Traina F; Dunbar CE; Winkler T; Calado RT
    Stem Cell Res; 2019 Oct; 40():101540. PubMed ID: 31479877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of dyskeratosis congenita-like hematopoietic stem cells through the stable inhibition of DKC1.
    Carrascoso-Rubio C; Zittersteijn HA; Pintado-Berninches L; Fernández-Varas B; Lozano ML; Manguan-Garcia C; Sastre L; Bueren JA; Perona R; Guenechea G
    Stem Cell Res Ther; 2021 Jan; 12(1):92. PubMed ID: 33514435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The C-terminal extension of dyskerin is a dyskeratosis congenita mutational hotspot that modulates interaction with telomerase RNA and subcellular localization.
    Qin J; Garus A; Autexier C
    Hum Mol Genet; 2024 Feb; 33(4):318-332. PubMed ID: 37879098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intron retention by a novel intronic mutation in DKC1 gene caused recurrent still birth and early death in a Chinese family.
    Guo Q; Zhang P; Ying W; Wang Y; Zhu J; Li G; Wang H; Wang X; Lei C; Zhou W; Sun J; Wu B
    Mol Genet Genomic Med; 2022 Jun; 10(6):e1934. PubMed ID: 35384376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased dyskerin levels as a mechanism of telomere shortening in X-linked dyskeratosis congenita.
    Parry EM; Alder JK; Lee SS; Phillips JA; Loyd JE; Duggal P; Armanios M
    J Med Genet; 2011 May; 48(5):327-33. PubMed ID: 21415081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synonymous Mutation in DKC1 Causes Telomerase RNA Insufficiency Manifesting as Familial Pulmonary Fibrosis.
    Gaysinskaya V; Stanley SE; Adam S; Armanios M
    Chest; 2020 Dec; 158(6):2449-2457. PubMed ID: 32710892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity of X-linked dyskeratosis congenita (DKCX) cellular defects is not directly related to dyskerin (DKC1) activity in ribosomal RNA biogenesis or mRNA translation.
    Thumati NR; Zeng XL; Au HH; Jang CJ; Jan E; Wong JM
    Hum Mutat; 2013 Dec; 34(12):1698-707. PubMed ID: 24115260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated hematopoietic stem cell aging in a mouse model of dyskeratosis congenita responds to antioxidant treatment.
    Gu BW; Fan JM; Bessler M; Mason PJ
    Aging Cell; 2011 Apr; 10(2):338-48. PubMed ID: 21241452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyskeratosis congenita with a novel genetic variant in the DKC1 gene: a case report.
    Ratnasamy V; Navaneethakrishnan S; Sirisena ND; Grüning NM; Brandau O; Thirunavukarasu K; Dagnall CL; McReynolds LJ; Savage SA; Dissanayake VHW
    BMC Med Genet; 2018 May; 19(1):85. PubMed ID: 29801475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyskeratosis congenita: telomerase, telomeres and anticipation.
    Marrone A; Walne A; Dokal I
    Curr Opin Genet Dev; 2005 Jun; 15(3):249-57. PubMed ID: 15917199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyskeratosis congenita mutations in dyskerin SUMOylation consensus sites lead to impaired telomerase RNA accumulation and telomere defects.
    Brault ME; Lauzon C; Autexier C
    Hum Mol Genet; 2013 Sep; 22(17):3498-507. PubMed ID: 23660516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical inhibition of PAPD5/7 rescues telomerase function and hematopoiesis in dyskeratosis congenita.
    Shukla S; Jeong HC; Sturgeon CM; Parker R; Batista LFZ
    Blood Adv; 2020 Jun; 4(12):2717-2722. PubMed ID: 32559291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High resolution melting analysis for the identification of novel mutations in DKC1 and TERT genes in patients with dyskeratosis congenita.
    Carrillo J; Martínez P; Solera J; Moratilla C; González A; Manguán-García C; Aymerich M; Canal L; Del Campo M; Dapena JL; Escoda L; García-Sagredo JM; Martín-Sala S; Rives S; Sevilla J; Sastre L; Perona R
    Blood Cells Mol Dis; 2012 Oct 15-Dec 15; 49(3-4):140-6. PubMed ID: 22664374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.
    Marrone A; Dokal I
    Expert Rev Mol Med; 2004 Dec; 6(26):1-23. PubMed ID: 15613268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells.
    Batista LF; Pech MF; Zhong FL; Nguyen HN; Xie KT; Zaug AJ; Crary SM; Choi J; Sebastiano V; Cherry A; Giri N; Wernig M; Alter BP; Cech TR; Savage SA; Reijo Pera RA; Artandi SE
    Nature; 2011 May; 474(7351):399-402. PubMed ID: 21602826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyskeratosis congenita: a genetic disorder of many faces.
    Kirwan M; Dokal I
    Clin Genet; 2008 Feb; 73(2):103-12. PubMed ID: 18005359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostics of rare disorders: whole-exome sequencing deciphering locus heterogeneity in telomere biology disorders.
    Trotta L; Norberg A; Taskinen M; Béziat V; Degerman S; Wartiovaara-Kautto U; Välimaa H; Jahnukainen K; Casanova JL; Seppänen M; Saarela J; Koskenvuo M; Martelius T
    Orphanet J Rare Dis; 2018 Aug; 13(1):139. PubMed ID: 30115091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.